Novacyt loss narrows 9% to GBP 5.79 million in six months to June 30, 2026
Loss after tax attributable to owners narrowed 9% to GBP 5.79 million; revenue rose 18% to GBP 11.56 million for the six months ended June 30, 2026.
Loss after tax attributable to owners narrowed 9% to GBP 5.79 million; revenue rose 18% to GBP 11.56 million for the six months ended June 30, 2026.